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Molecular docking is themost practical approach to leverage protein structure for ligand discovery, but
the technique retains important liabilities that make it challenging to deploy on a large scale. We have
therefore created an expert system, DOCKBlaster, to investigate the feasibility of full automation. The
method requires a PDB code, sometimes with a ligand structure, and from that alone can launch a full
screen of large libraries. A critical feature is self-assessment, which estimates the anticipated reliability of
the automated screening results using pose fidelity and enrichment. Against common benchmarks,
DOCKBlaster recapitulates the crystal ligand pose within 2 A˚ rmsd 50-60% of the time; inferior to an
expert, but respectrable. Half the time the ligand also ranked among the top 5% of 100 physically
matched decoys chosen on the fly. Further tests were undertaken culminating in a study of 7755 eligible
PDB structures. In 1398 cases, the redocked ligand ranked in the top 5% of 100 property-matched
decoys while also posing within 2 A˚ rmsd, suggesting that unsupervised prospective docking is viable.
DOCK Blaster is available at http://blaster.docking.org.
Introduction
Molecular docking has had important recent successes1-12
and is nowwidely used in industry and academia. Butwhereas
other techniques in computational biology such as homology
modeling13 and sequence database searching14 have been
successfully deployed on a proteomic scale, docking has
remained manually intensive. Docking programs are challen-
ging touse, withmanyparameters tobe chosen, file formats to
be manipulated, and decisions to be made at both the pre-
paration and analysis stages. Even in expert hands, there are
targets for which docking simply fails to recapitulate experi-
mentally known binding information. These barriers to entry
have diminished the impact of the technique by making it less
accessible to biologically oriented nonexperts and challenging
even for specialists to deploy on a large scale.
One approach to make docking accessible to more investi-
gators, and to make it more systematic even for experts, is to
automate it. We have therefore investigated an expert system,
DOCKBlaster, which aims to emulate experts at all stages of
the docking process. Ideally, DOCK Blaster could start from
as little as a PDBa code and from that launch a full screen of a
large compound library to find novel ligands. To do so itmust
overcome substantial challenges in preparing a target site for
docking, it must explore variation in the sampling and often
scoring, and it must conduct control calculations to judge the
quality of the screen. For instance, the automated procedure
must recognize common cofactors, metals, post-translational
modifications, and solutes to identify the ligand and separate
it from the receptor. Second, “hot spots” for docking must be
identified for a wide range of binding site sizes and shapes.
Third, parameters must be assigned to receptor atoms in a
robust way that can cope not only with cofactors, metals, and
post-translational modifications but also with unforeseen
moieties for which no dictionary is available. Because an
expert would normally experiment with several variations in
sampling and scoring, an automated system should do so also,
picking the best parameters to use for a full database screen.
Finally, the entire docking process should be integrated from
end to end so as to recover from simple problems, continue as
far as possible, and end gracefully should an unrecoverable
error occur.
Here we describe DOCK Blaster, a fully automated dock-
ing system including self-assessment. Themethod is tested for
pose-fidelity, the ability to reproduce experimentally observed
poses within some tolerance limit, and enrichment, the ability
to enrich actives from among a database of decoys, where a
decoy is a member of the database that does not bind to the
target. We have used three of the most common benchmark-
ing sets: the Astex-85 set,7 having 85 high-quality crystal
structures of therapeutically relevant targets and “drug-like”
ligands, the GOLD-114 benchmark,15 derived from the most
widely used docking benchmarks,16,17 and the DUD set,27 38
protein targets for which sets of annotated actives and corre-
sponding property-matched decoys are available for each
target. Property-matched decoys have similar physical prop-
erties but different topologies that one would not expect
should be recognized by the protein, a key requirement for a
high score. Whereas we find that the automated method is
typically outperformed by an expert, its performance is never-
theless respectable.
*To whom correspondence should be addressed. Phone: 415-514-
4127. Fax: 415-514-4260. E-mail: jji@cgl.ucsf.edu.
aAbbreviations: rmsd, rootmean squared deviation; SAR, structure-
activity relationship; PDB, Protein Data Bank; ROC, receiver operator
characteristic.
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In principle, such an automated procedure could bring
docking to a much larger community and could be used to
explore targets on a proteomic scale. For the first goal to
providemore good than harm, it is important to providewhat
mayoften be naı¨ve userswith anautomated self-assessment of
the docking results. We investigate methods to do so using
pose fidelity and enrichment based on a single observed
crystallographic ligand. To investigate the plausibility of the
second goal, we describe here docking screens on 7755 protein
targets where each screen is performed against a feasibility
library of 100 molecules.
Methods
DOCKBlaster is composed of an expert system engine and
aweb-enabled user interface (Figure 1). The docking program
used is DOCK 3.5.54,28,29 a version of UCSF DOCK. The
DOCKBlaster pipeline is composedof sixmodules (Figure 2):
(a) the parser, which identifies the receptor and ligand from a
PDB file, (b) the scrutinizer, which attempts to correct for
problems, such as incomplete or disordered residues on the
receptor, (c) the preparer, which protonates the receptor,
calculates “hot spots” and scoring grids, assigns atomic para-
meters, including these for cofactors, post-translational mod-
ifications andmetals, and prepares the ligand, decoys, andany
actives and inactives for docking, (d) the calibrator, whichuses
supplied data to assess docking performance and suggests
optimal docking parameters, (e) the docker, which manages a
full database screen on the computer cluster, and (f) the
assessor, which prepares reports to interpret database screen-
ing results. We take up each module in turn.
a. The Parser. This expert system starts with a PDB code.
The file is retrieved directly from the PDB Web site with no
preprocessing. The Parser uses dictionaries of common
cofactors, ions, post-translationalmodifications, and solutes
to identify and separate the ligand from the receptor. If the
ligand itself is a common solute or cofactor, a three letter
code of the ligand must be specified. If more than one ligand
is available, the Parser asks the user to pick one. In fully
automated screens, such ambiguity stops the procedure. If
no ligand can be identified, the Parser also halts the calcula-
tion with an error message. A future version may use auto-
matic binding site identification software30-32 to identify the
binding site in this case. The Parser produces files that are
ready to be used by the scrutinizer in the next step andmay be
accessed online at http://blaster.docking.org/parser.shtml.
b. The Scrutinizer. The Scrutinizer takes as input a target
structure and a specification of the binding site, which may
be either a docked ligand in mol2 format or atoms in or near
the binding site in PDB format. The Scrutinizer checks that
the receptor and ligand are properly formatted, and that at
least one atom of the ligand is within a binding site on the
protein. This step also attempts to flesh out incomplete
residues and pick the first of any disorder models present.
The Scrutinizer can take input directly from the parser
(module a, above) or from the job preparation page, http://
blaster.docking.org/start.shtml.
c. The Preparer. The Preparer is an expert system that
performs actions necessary before docking can begin. This
includes maturing the receptor model by removal of ordered
water molecules, protonation of receptor atoms to a united
atom model, and assignment of AMBER atom types33
including to metals, cofactors, and post-translational mod-
ifications that are effectively part of the receptor. Subse-
quently docking “hot spots” are calculated by sphgen,34
while van der Waals and electrostatics scoring grids are
calculated by chemgrid35 and Delphi,36 respectively. To
correct for ligand desolvation, solvmap37 is used to calculate
a solvent occlusion grid. To prepare a dockable database of
the ligand and any actives and inactive controls, the PDB
format ligand is converted to SMILES using OpenEye’s
OEChem38 to eliminate bias. The molecule is then processed
using the standard ZINC protocol,39 which aims to enumer-
ate all physiologically relevant protonated and tautomeric
forms of the molecule. In parallel, property-matched decoys
for the ligand are found from ZINC using the DUD proto-
cols27,40 for enrichment and ranking.
Figure 1. TheDOCKBlaster web interface, available starting from
http://blaster.docking.org/.
Figure 2. DOCK Blaster pipeline schematic. Left: two starting
points for DOCK Blaster. Center: six main modules of the auto-
matic docking pipeline. Right: four places in which automatic
docking can fail.
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Four parameter sets are evaluated by performing sam-
pling and scoring each in two different ways. DOCK Blaster
uses two different sampling schemes called “coarser” and
“finer” to sample fewer or more ligand orientations by
adjusting the bins used to generate initial orientations. The
“coarser” scheme uses 45 “hot spots” and wider bins and
generally runs somewhat faster, whereas “finer” uses 55 “hot
spots”, narrower bins, and is often slower. Two scoring
schemes called “polarized” and “normal” are also used.
The “normal” scheme uses standard AMBER 94 partial
atomic charges on the protein, while “polarized” increases
the dipoles on selected polar atoms in residueswithin 3.5 A˚ of
the crystallographic ligand without changing the net charge.
In prospective studies involving experimental testing of
novel inhibitors, we have found such limited polarization
useful.41-44 Each ligand configuration that passes a rapid
steric fit filter is scored for electrostatic and van der Waals
complementarity and adjusted for partial ligand desolvation
due to solvent occlusion.37 The high-scoring ligand confor-
mation is minimized with 100 steps of simplex rigid-body
minimization. More details of these schemes and other
technical details may be found on the DOCK Blaster docu-
mentation Web site, http://disi.docking.org/DOCK_Bla-
ster:Technical_Details.
d. The Calibrator. This subsystem evaluates how well
docking works as judged by pose fidelity to the crystal
structure and by enrichment versus decoys. In doing so, this
tool selects the best docking parameters for a full database
screen. It first redocks the ligand using all four docking
parameter sets. It evaluates pose fidelity using the rmsd of all
non-H atoms to the crystallographic pose and calculates the
rank of the redocked ligand among the 100 property-
matched decoys, which are also docked using all four dock-
ing parameter sets. If actives and inactives were supplied, as
is the case for the DUD benchmark, these are also docked
and ROC plots are calculated.
A concise calibration docking report allows users to judge
which parametrization, if any, is best for prospective docking
(Figure 3). Outcomes are color coded to indicate successful
(in green), unsuccessful (in red), and borderline (in yellow)
results. Particularly for borderline cases, the usermaywish to
inspect the scores and poses of each ligand and decoy before
selecting the best parametrization for prospective docking.
e. TheDocker.Thismodule screens (potentially very large)
ZINC subsets on a computer cluster. It is normally only
invoked after the calibrator has established that docking is
viable. The most successful set of docking parameters from
the calibration phase is selected and used. The Docker
manages the screen across multiple CPUs, combining the
results when the entire library has been searched.
f. The Assessor. When database docking is complete, the
Assessor prepares reports including full purchasing informa-
tion, annotation of physical properties, annotation of known
activities derived from public data sources, and similarity to
annotated compounds, other top hits, and other purchasable
compounds. Docked structures may be viewed in the context
of the binding site using PyMol,45Chimera46 or JMol.47 These
reports may be browsed online or downloaded in tab-delim-
ited format for processing by analysis software such as Excel.
DOCK Blaster is accessible via a web-based interface at
http://blaster.docking.org (Figure 1). It is hosted on a cluster
of 700 CPU cores managed using the Sun Grid Engine with
access to 30 terabytes of RAID-6 storage. DOCK Blaster is
integrated with ZINC,39 a public access database of com-
mercially available compounds for library screening, and the
DUD Decoy Maker,27,40 which are also accessible sepa-
rately. We do preserve the results of some screens, which
we may use for methods development and analyses.
DOCKBlaster was tested using ligand-bound crystal struc-
tures from the PDB,48 including some of the most widely
used benchmarking standards: Astex-85,7 GOLD-11415, and
DUD-3827 (release 2, Oct 2006). We have used only the 38
structures in DUD for which a ligand-bound crystal structure
is available. We have used only postremediation49 PDB
structures for which a single small (<500 Da) organic ligand
is bound, having 2.5 A˚ resolution or better, and no poly-
nucleotides.
Results
DOCK Blaster is a new tool for automatic docking and is
available for free anonymous public access at http://blaster.
docking.org. DOCK Blaster can start from the structure of a
target and a specification of the binding site or simply from a
PDB code in many cases. To assess the performance of our
automatic high throughput docking procedure retrospec-
tively, we turned to common benchmarks in the field: Astex-
85,7GOLD-114,15 andDUD-38.27Webeganby retrieving the
files directly from the remediated49 PDB and used the parser
to automatically separate the ligand from the receptor. In all
but a few cases, the parser succeeded well enough in this task
to proceed to docking (Supporting Information Table S1).
Occasionally the ligand could not be identified automatically.
One reason was that the ligand was a common solute such as
citrate. These could be rescued by simply specifying the three
letter code of the ligand to the parser. The average total CPU
time per target, from preparation to docking the ligand and
its 100 decoys to final analysis of the results, all automated,
was 92 min.
Astex-85 Benchmarking.We began by using DOCK Blas-
ter to automatically dock to targets in theAstex-85 set.7 In all
but one case, the ligand was automatically separated from
the protein starting from the PDB code alone (Supporting
Information Table S1). For 1LF7, we were required to
specify the ligand (citrate, CIT) because it is a common
solute. Of the 84 jobs started automatically, 83 finished
normally and produced a docked pose and score for the
ligand and its decoys (Supporting Information Table S2).
One ligand failed during conversion to SMILES (1U4D).
We asked how well automatic docking could recapitulate
the crystal structure using each of four docking parameter
sets. Of the 83 protein-ligand pairs that yielded a docked
ligand score, 51 were within 2 A˚ rmsd of the crystal structure
Figure 3. Calibration docking report, containing pose fidelity (A˚,
rmsd) and enrichment (% rank) of the redocked crystallographic
ligand compared to 100 property matched decoys using four para-
metrizations, separated by a forward slash (/) in each cell. Successful
runs are in green, unsuccessful ones in red, and marginal ones in
yellow.
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(Supporting InformationTable S2 , and http://data.docking.
org/2009/AstexTables.doc). Some parametrization schemes
were more successful than others. The best was “finer/
polarized” with 49 successes, followed by “finer/normal”
with 46, “coarser/polarized” with 37, and the least successful
being “coarser/normal” with 34 successes. The “finer”
schemes having more spheres generally outperformed the
“coarser” schemes, although this was not always true. The
polarized dipoles in the electrostatics of “polarized” were
slightly more successful than the “normal” scheme having
standard AMBER94 charges on the protein.
For the 51 protein-ligand complexes docked within 2 A˚
rmsd of the crystal pose, we then asked how well the
redocked crystallographic ligand ranked compared to
around 100 property-matched decoys (Tables 1 and 2 and
http://data.docking.org/2009/AstexTables.doc). The well-
posed ligand also ranked in the top 5% of the property
matched decoys in 29 cases, suggesting that these are suitable
for automatic prospective docking. Just beyond the 2 A˚
cutoff, there were 11 cases in which the ligand posed close,
within 3 A˚, and a further 20 cases where the ligand never got
even as close as 3 A˚ rmsd to the crystallographic ligand.
For 18 targets, the results were excellent regardless of
which docking parameter set was chosen; we could find no
common theme among the targets to which to attribute this
good fortune (Figure 4). There were three nuclear receptors
(1M2Z, 1N46, 1SQN), six kinases (1KE5, 1OPK, 1YWR,
1V4S, 1PMN, 1T46), and seven other enzymes (1HWI,
1OF6, 1LPZ, 1Q4G, 1JLA, 1R9O, 1VCJ). There was no
obvious pattern in the physical or chemical properties of the
ligands to explain why these targets worked so reliably. We
did notice some patterns among the less successful docking
calculations, however.
Five targets achieved good poses with all parametriza-
tions, yet the ligand never ranked well (Figure 5 and http://
data.docking.org/2009/AstexTables.doc, class 4): 1IA1,
1J3J, 1TZ8, 1XM6, and 1XOQ. These cases are interesting
because pose fidelity is often used as a metric for docking
success. Poor ranks despite good poses can arise when either
the ligand scores unexpectedly poorly or the decoys score
unexpectedly well. For instance, many decoys for 1IA1,
dihydrofolate reductase (DHFR), contained guanidinium
and other groups that might well bind to DHFR and in turn
received excellent scores. Because the ligands looked compe-
titive to us, we attribute the failure to achieve a good rank as
being due to highly competitive decoys rather than a failure
of the ligand itself, as it also received a good score. Future
work will investigate whether the decoy selection procedure
might be improved to remove viable-looking ligands that are
not currently eliminated by our fingerprint-based dissimilar-
ity metric.
Failure to achieve even a good pose against perhaps
20-30% of targets is common in docking studies, so we
were not much surprised to note 31 targets where the ligand
did not dock even close (within 3 A˚ rmsd) to a satisfactory
pose (Figure 6 and http://data.docking.org/2009/AstexTa-
bles.doc, class 6). Many of these pose fidelity failures could
be attributed to one of four common causes: (a) insufficient
conformational sampling of the ligand, particularly of ali-
phatic ring puckering, (b) symmetric or pseudosymmetric
molecule, (c) critical missing water molecules, and (d) ligand
pose dominated by electronic (orbital) effects. These issues
are common to all docking methods and protocols and are
therefore expected for this study. In the scripted, automatic
context of DOCK Blaster, some of these problems could be
addressed, for instance by using a rescoring method to allow
for relaxation of ring puckering or an approach that samples
explicit water molecule positions.50 Other failures, such as
the plausible reversed docking pose of a pseudosymmetrical
molecule in 1YV3, could be better addressed using a density-
based pose-assessmentmethod.51 Some failures are probably
simply beyond the capabilities of an orbital-naı¨ve method
like DOCK, such as 1P2Y, a P450, where the ligand pose
appears to be under electronic rather than steric control.
Whereas some of these failures may be addressed by im-
provements in the protocol, we worry about a tendency to
build in toomuch “expertise” that leads to over fitting. Some
of these problem targets will likely remain beyond the
capability of full automation, at least in the near term.
With four parameter sets to choose from, we wondered
whether one of them was more successful at achieving good
pose fidelity than the others. To answer this, we plotted the
frequency and cumulative frequency of pose fidelity for the
best parameter set for each case (Figure 7) and also for each
parameter set separately (Supporting Information Figure S1).
We found that all parameter sets achieved a pose within 2 A˚
rmsd at least 50% of the time. The “finer” schemes performed
slightly better at 60%.These graphs confirm that all parameter
sets are roughly comparable at achieving good ligand poses,
that each is best some of the time, and none of the parame-
trizations is either much better or much worse than average.
We wondered whether better pose fidelity could be used to
predict rank. If it were, good pose fidelity as measured by
rmsd could be used to select the best docking parameters.We
plotted pose fidelity (A˚, rmsd) versus rank using the para-
meters that led to the best pose fidelity in each case (Figure 8)
and also for each parameter set separately (Supporting
Information Figure S2). Poor pose fidelity was generally
associated with poorly ranked compounds, although there
was one notable exception, beta II tryptase (2BM2), where
the ligand docked backward but still managed to get a good
score compared to its decoys. However, good pose fidelity
was entirely uncorrelated with rank, regardless of which
parameter set was used. It would thus appear that pose
fidelity cannot be used to predict rank and thus whether
the model is suitable for prospective docking.
Table 1. Docking Successes with DOCK Blastera
Outcome Astex-85 Gold-114 DUD-38 PDB-9050
success 29 27 15 1398
ligand never
ranks well
44 67 21 6357
ligand fails
to dock
automatically
2 20 2 1295
aNumber of targets where fully automatic docking with DOCK
blaster is successful, as judged by both good pose fidelity (< 2.0 A˚
RMSD) and rank (top 5%) versus about 100 property-matched
decoys.
Table 2. Docking Success Depends on Docking Parametersa
parameter choice DOCK score ScreenScore FlexX PLP PMF
all 18 18 16 18 10
any 29 36 33 38 22
a Success is defined as ligandwithin 2 A˚RMSDof the crystal pose and
rank in the top 5% of about 100 property-matched decoys. Astex-85
benchmark. For instance, whereas 29 targets succeeded for pose fidelity
and rank using any of four parameter sets and the standard DOCK
scoring function, only 18 of these succeeded with all parameter sets.
5716 Journal of Medicinal Chemistry, 2009, Vol. 52, No. 18 Irwin et al.
Wewere curious aboutwhether ligand rankwas sensitive to
the scoring function used. To explore this, we rescored the
ligand and all its decoys as docked using DOCK with four
widely used, different scoring functions (Table 2 and http://
data.docking.org/2009/RescoringTables.doc), in each case
without any change to the receptor or ligand structure. Three
of the scoring functions ranked the ligand substantially higher
compared to the decoys, resulting in between 4 and 9 more
successes. Only PMF resulted in fewer successes thanDOCK.
GOLD-114 Benchmarking. Because we used the Astex-85
set to tune our protocol and parameter choices, we worried
about overfitting.52 To control for protocol bias, we turned
to the GOLD-114 benchmark15 for which we did not allow
ourselves to adjust the automatic procedure or its parameters
in any way. A total of 75 targets were successfully sepa-
rated into ligand and receptor automatically from the PDB
code alone (Supporting Information Table S1), and a fur-
ther 19 cases (94 total) could be run if the ligand three letter
Figure 4. Ligands from theAstex-85 benchmarks that redockwith goodpose fidelity and good rank (top 5%of propertymatched decoys)with
all parameter sets used. (A) Nuclear hormone receptors (B) kinases (C) other enzymes.
Figure 5. Ligands from the Astex-85 benchmarks that redock with good pose fidelity but poor rank compared to property-matched decoys.
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code was also specified. Of the 94 calculations that started
automatically, all but two yielded a docked pose and score
for the ligand. Of the 20 targets that failed to produce a
docked ligand, three failed during ligand identification and
separation, five failed to prepare the ligand for docking, and
12 tried but failed to dock and score the ligand.
We asked how well automatic docking could recapitulate
the crystal structure when the docking protocol could not be
modified.Of the 92 that yielded a docked and scored ligand, 58
posed within 2 A˚ rmsd of the crystal structure (Supporting
Information Table S2 and http://data.docking.org/2009/
GOLDTables.doc). All parameter sets performed nearly
equivalently, and no single one was as successful as combining
the best result from all four.When the docked pose was within
2 A˚ rmsd, 27 of these also managed to rank in the top 5% of
about 100 property matched decoys (Table 1 and http://data.
docking.org/2009/GOLDTables.doc).
DUD Benchmarking. Worrying about depending on a
single positive control as the sole basis for judging docking
performance, we turned to a benchmark for which more
actives were available. We used DOCK Blaster to dock to
targets in the DUD-38 benchmark27 for which the ligand
pose was crystallographically observed. All targets could be
handled by the parser and submitted to the DOCK Blaster
queue. One ligand failed to be converted to SMILES auto-
matically (1CKP), but the rest of the 37 targets completed
normally yielding a redocked and scored ligand.
We began by assessing performance as before using a
single crystallographic ligand and its automatically gener-
ated decoys, asking how well automatic docking could
recapitulate the crystal structure. Of the 37 protein-ligand
pairs that yielded a docked ligand score, 23 posed within 2 A˚
rmsd of the crystallographic ligand (Supporting Information
Table S2 and http://data.docking.org/2009/DUDTables.
doc). When the docked pose was within 2 A˚ rmsd, 15 of
these also ranked the ligand in the top 5% of about 100
property matched decoys (Table 1 and http://data.docking.
org/2009/DUDTables.doc).
As part of DUD, these targets benefited from between 20
and 600 additional annotated actives and their correspond-
ing property-matched decoys with which to test DOCK
Blaster. We began by checking that the fully automatic
docking results using DOCK Blaster were at least compar-
able to the expert docking reported in the DUD paper
(Figure 9 and Supporting Information Table S3). If auto-
matic docking were consistently different from an expert, the
conclusions of this study could be undermined. For instance,
an expert can experiment with the placement of specific
water molecules, modification of receptor parameters, or
docking parameters and do so repeatedly until the results
converge. Whereas fully automated docking often produced
results somewhat inferior to an expert, we thought it was
close in all but five cases.
A critical question was how predictive the single molecule
metric used thus far was of the multimolecule DUD metric
(Table 3 and http://data.docking.org/2009/). For simplicity
we rated each metric as “good” or “bad” to indicate whether
the docking results looked compelling enough to use for a
discovery project. For the single ligand metric, “good”
meant both pose fidelity within 2 A˚ rmsd and rank strictly
in the top 5% of the property matched decoys. For the
multiligand (DUD) metric, “good” meant that either the
adjusted logAUC53 was greater than 10, or that EF1, the
Figure 8. Plot of pose fidelity (A˚, rmsd) versus% rank compared to
about 100 property matched decoys (log scale). For Astex-85
benchmark. In each case, the parameter set that gave the best pose
fidelity was used.
Figure 7. Histogram and cumulative frequency of pose fidelity
(A˚, rmsd) using the best parameter set. Astex-85 benchmark.
Figure 6. Ligands from the Astex-85 benchmark that do not achieve good pose fidelity under any circumstances.
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fraction of ligands found by the first percentile, was greater
than 10%, or that EF5 was greater than 20%. Our results
show that in 26 of 36 or 72% of cases where automatic
docking completed normally, the single ligand metric of
docking success predicted the multiligand assessment. This
result allows us to deploy the single ligand metric as a
reasonable predictor of overall enrichment.
PDB Benchmarking. A common criticism of docking is
that it often seems to encounter unforeseen problems with
each new target, and correspondingly one never knows in
advance whether docking will “work”. Equipped with a
fully automated system and single-ligand based assessment
tools, we turned to a larger set of targets to investigate the
prevalence of situations that are not well handled by our
scripts. Of the 9050 eligible PDB targets submitted to the
parser, 7755 produced a docked ligand structure that could
be scored and ranked (Table 4). Of these, 3056 had the
ligand redock within 2 A˚ rmsd of the crystal structure
(http://data.docking.org/2009/PDB3056.xls). About 100
property-matched decoys were generated automatically
for each ligand, docked, and used to calculate the rank of
the redocked ligand using each of four parameter sets. In
1398 of these cases, the ligand also scored in the top 5%,
representing 18% of the 7755 targets that were viable for
automatic docking.
Discussion
Recognizing the potential benefit of automated high
throughput docking to interpret the growing number of
protein structures, we have developed an automatic docking
Figure 9. Receiver operator characteristic (ROC) plots comparing enrichment byDOCKBlaster (magenta) versus an expert (dark blue) against
four targets from the DUD benchmark. (A) COX-2 (B) RXR alpha (C) ER-agonist (D) SAHH. Random enrichment shown by a thin gray line.
Table 3. Correlation ofDocking SuccessAssessment between the Single
MoleculeMetric andMultipleMoleculeMetric for the DUD-38 Bench-
mark. a
single molecule metric
multiple molecule
metric (DUD) good bad
good 12 6
bad 4 14
a Success for the single molecule metric has pose fidelity within 2 A˚
RMSD and rank in the top 5%of property-matched decoys. Success for
the DUD metric is adjusted logAUC > 10 or EF1 > 10% or EF5 >
20%. Diagonal: 26. Off diagonal: 10. Automatic docking failure: 2.
Correlation: 72%.
Table 4. Attrition of PDB Structures Subjected to Fully Automated
Docking Using DOCK Blastera
count
as % of
previous row
ligand identified, DOCK
Blaster job started
9050
ligand docked and scored 7755 86
pose good (<2 A˚ rmsd) 3056 39
may be useful prospectively
(<2 A˚ rmsd; rank top 5%)
1398 46
aAug 1, 2008 version, of the PDB having 52000 x-ray crystal
structures in total.
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system and assessed its performance in retrospective tests.
Five results emerge from this study. First, DOCK Blaster, an
automatic docking system, is now available for free public use
and can produce useful results starting with as little as a PDB
code. Second, useful results as judged by good pose fidelity
and rank compared to property matched decoys were
achieved in around 30% of cases against common bench-
marks. Third, surprisingly, pose fidelity as measured by rmsd
is not predictive of rank and is therefore not a useful metric of
docking success by itself.54Fourth, a single ligandmetric using
the crystallographic ligand is predictive of the multiligand
enrichment over property-matched decoys 72% of the time.
Finally, DOCK Blaster has been deployed on a large scale
and produced screening results that deserve further considera-
tion for experimental testing in 1398 of 7755 cases drawn
from the PDB.
The result that will have perhaps the greatest pragmatic
impact is the creation of the DOCK Blaster server itself.
Because DOCKBlaster can start from as little as a PDB code,
can produce results like an expert in some cases, and can self-
evaluate, it is suitable for use by nonexperts and for large-scale
experiments. When docking performs poorly or fails comple-
tely, this canusually be deduced automatically from failures in
pose fidelity and rank-to-decoys statistics. Thus the prospec-
tive user of this system can estimate whether the docking
results are likely to be useful for discovery, should be ignored
completely, or perhaps fall somewhere in between. Of course,
any system of this complexity is bound to have flaws, and
some projects will simply not work. Still, it is our hope that
DOCKBlasterwill be useful for nonexperts, lowering barriers
to entry to the field.
Pose fidelity using DOCKBlaster in retrospective studies is
not quite as good aswhen performed by an expert. Our black-
box system achieves pose fidelity within 2 A˚ rmsd for about
50-60% of targets, compared to 70-80% for expert-guided
docking. Perhaps surprisingly, pose fidelity as measured by
rmsd deviation did not correlate at all with rank. For enrich-
ment, again our results are not quite as good as reported in
other available studies. This should be unsurprising, however,
because experts are at liberty tomanually curate sites, ligands,
and protocols to maximize performance. Useful results, i.e.,
good pose fidelity and good enrichment, were obtained in
25-40% of benchmark cases. The success rates for Astex-85
was 29 out of 85, for GOLD-114 it was 27 out of 114, and for
DUD-38 15 out of 38 were successful for both pose-fidelity
and enrichment. Whereas this might not seem a very high
success rate, no study has ever held itself to such a stringent
standardbefore, and thiswas only possiblewith anautomated
program.
As a basis for performance assessment, a single ligand with
generated property-matched decoys predicts the multiligand
assessment three times out of four. Because only one ligand is
needed, this has significant advantages for automation, en-
abling automatic self-assessment of docking results, which
would be impractical if a list of actives had to be assembled to
benchmark each target.The correlationwas largely insensitive
to the precise cutoffs used to characterize docking success or
to which scoring function was used. Of course, this result is
provisional, as it is basedon theDUD-38benchmarkandmay
be revised as larger benchmarks appear.
DOCK Blaster has been deployed on a near-proteome
scale, and produced useful results for 1398 of 7755 targets or
18% of the PDB structures that were amenable to this
method. Because docking can recapitulate what is already
known about the site in these cases, there is a reasonable hope
for prospective docking to suggest ligands that might actually
bind. Many of these problems were previously known
(conformational sampling, ligand representation, structural
waters), but their prevalence is now better quantified.
There is a critical need to find new small molecule reagents
for biology. At the same time, a rapidly growing backlog of
uninterpreted structures has accumulated in the PDB. Yet in
an age of plentiful target structures, freely available small
molecule databases, many sophisticated docking programs,
and fast computers to run them on, many biologically or-
iented investigators still find docking for ligand discovery
daunting. We have developed DOCK Blaster to help non-
specialists find new reagents for biology without the need for
an expert. As for experts, DOCK Blaster does not produce
compelling results for all targets. But for the nearly 20% of
targets we tried where it does produce results deserving of
further investigation, DOCK Blaster offers a way to auto-
matically leverage structure for ligand discovery.
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